Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results.

被引:3
|
作者
Gramza, A. W. [1 ]
Wells, S. A. [1 ]
Balasubramaniam, S. [1 ]
Fojo, A. T. [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.5565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5565
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Phase I Trial of Vandetanib Plus Sirolimus in Adults with Recurrent Glioblastoma
    Chheda, Milan
    Wen, Patrick
    Hochberg, Fred
    Chi, Andrew
    Drappatz, Jan
    Yang, Daniel
    Eichler, April
    Beroukhim, Rameen
    Norden, Andrew
    Gerstner, Elizabeth
    Batchelor, Tracy
    NEUROLOGY, 2012, 78
  • [32] A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
    Noelle K. LoConte
    James P. Thomas
    Dona Alberti
    Jennifer Heideman
    Kimberly Binger
    Rebecca Marnocha
    Kyle Utecht
    Peter Geiger
    Jens Eickhoff
    George Wilding
    Jill Kolesar
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 109 - 115
  • [33] A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
    LoConte, Noelle K.
    Thomas, James P.
    Alberti, Dona
    Heideman, Jennifer
    Binger, Kimberly
    Marnocha, Rebecca
    Utecht, Kyle
    Geiger, Peter
    Eickhoff, Jens
    Wilding, George
    Kolesar, Jill
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 109 - 115
  • [34] A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results.
    Lunning, Matthew Alexander
    Ruan, Jia
    Nair, Sumithra
    Boruchov, Adam M.
    Byrne, Regina
    Gerecitano, John F.
    Hamlin, Paul A.
    Inserra, Beth
    Leonard, John
    Lynch, Peggy
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Moskowitz, Craig
    Myskowski, Patricia L.
    Nolan, Patrick
    Palomba, Maria Lia
    Quefeld, Christiane
    Straus, David J.
    Zelenetz, Andrew David
    Horwitz, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Phase I/II trial of bortezomib plus CHOP-Rituximab in diffuse large B cell (DLBCL) and mantle cell lymphoma (MCL): Phase I results.
    Leonard, JP
    Furman, RR
    Cheung, YKK
    Feldman, EJ
    Cho, HJ
    Vose, JM
    Nichols, G
    Glynn, PW
    Joyce, MA
    Ketas, J
    Ruan, J
    Carew, J
    Niesvizky, R
    LaCasce, A
    Chadburn, A
    Cesarman, E
    Coleman, M
    BLOOD, 2005, 106 (11) : 147A - 147A
  • [36] Lenalidomide and irinotecan in adults with recurrent malignant gliomas: Phase I results of the phase I/II trial
    Puduvalli, Vinay K.
    Groves, Morris D.
    Gilbert, Mark R.
    Hess, Kenneth R.
    Kang, Sanghee
    Ictech, Sandra
    Conrad, Charles A.
    Loghin, Monica Elena
    De Groot, John Frederick
    Levin, Victor A.
    Yung, W. K. Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Phase I/II trial of pembrolizumab in combination with binimetinib in unresectable locally advanced or metastatic triple negative breast cancer.
    Chumsri, Saranya
    Polley, Mei-Yin
    Anderson, Sarah L.
    O'Sullivan, Ciara Catherine Maria
    Colon-Otero, Gerardo
    Knutson, Keith L.
    Thompson, E. Aubrey
    Moreno-Aspitia, Alvaro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [38] A phase I/II trial of vandetanib for patients with recurrent malignant glioma
    Kreisl, Teri N.
    McNeill, Katharine A.
    Sul, Joohee
    Iwamoto, Fabio M.
    Shih, Joanna
    Fine, Howard A.
    NEURO-ONCOLOGY, 2012, 14 (12) : 1519 - 1526
  • [39] Phase I/II study of docetaxel plus FOLFOX in locally advanced or metastatic gastric cancer patients
    Filippelli, G.
    Lucia, M.
    La Gattuta, G.
    Caputo, A.
    Olivito, V
    Talarico, R.
    De Simone, R.
    Dima, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 28
  • [40] Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer
    Paridaens, Robert
    Dirix, Luc
    Dumez, Herlinde
    Prove, Annemie
    Wildiers, Hans
    Alvarez, Ana
    Oliveira, Celia Tosello
    Latz, Jane
    Simms, Lorinda
    Melemed, Allen
    CLINICAL BREAST CANCER, 2007, 7 (11) : 861 - 866